Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry (Q48401176)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 October 2009

Language	Label	Description	Also known as
English	Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry	scientific article published on 12 October 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

1 reference

based on heuristic

inferred from title

author name string

Shunji Tomatsu

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Adriana M Montaño

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Toshihiro Oguma

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Vu Chi Dung

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Hirotaka Oikawa

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

María L Gutiérrez

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Seiji Yamaguchi

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Yasuyuki Suzuki

8

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Masaru Fukushi

9

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Luis A Barrera

10

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Kazuhiro Kida

11

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Mitsuru Kubota

12

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Tadao Orii

13

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

publication date

12 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

99

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

124-131

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Clinical, biochemical, and ultrastructural studies in a case of chondrodystrophy presenting the I-cell phenotype in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

I-cell disease: multiple lysosomal-enzyme defect

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Prevalence of lysosomal storage disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Sacral dimple: incidental findings from newborn evaluation. Mucopolysaccharidosis IVA disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Enzyme-replacement therapy in mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Gene therapy for lysosomal storage diseases: the lessons and promise of animal models

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Cell and gene-based therapies for the lysosomal storage diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Urinary glycosaminoglycan excretion quantified by an automated semimicro method in specimens conveniently transported from around the globe

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Binding and detection of glycosaminoglycans immobilized on membranes treated with cationic detergents

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Characterization and Determination of Human Urinary Keratan Sulfate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Characterization of heparin oligosaccharide mixtures as ammonium salts using electrospray mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Analytical method of chondroitin/dermatan sulfates using high performance liquid chromatography/turbo ionspray ionization mass spectrometry: application to analyses of the tumor tissue sections on glass slides

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Analytical method for keratan sulfates by high-performance liquid chromatography/turbo-ionspray tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

High-performance liquid chromatographic-mass spectrometric analysis of oligosaccharides from enzymatic digestion of glycosaminoglycans. Application to human samples

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Characterization of the chemical structure of sulphated glycosaminoglycans after enzymatic digestion. Application of liquid chromatography-mass spectrometry with an atmospheric pressure interface

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Compositional analysis of glycosaminoglycans by electrospray mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Structural characterization of chondroitin/dermatan sulfate oligosaccharides from bovine aorta by capillary electrophoresis and electrospray ionization quadrupole time-of-flight tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Detection and quantification of sulfated disaccharides from keratan sulfate and chondroitin/dermatan sulfate during chick corneal development by ESI-MS/MS

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Analysis of keratan sulfate oligosaccharides by electrospray ionization tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Use of graphitised carbon negative ion LC–MS to analyse enzymatically digested glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Analysis of heparan sulfate oligosaccharides by nano-electrospray ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Compositional analysis and quantification of heparin and heparan sulfate by electrospray ionization ion trap mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Compositional profiling of heparin/heparan sulfate using mass spectrometry: assay for specificity of a novel extracellular human endosulfatase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Characterizing the non-reducing end structure of heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Liquid Chromatography/Mass Spectrometry Sequencing Approach for Highly Sulfated Heparin-derived Oligosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

High sensitivity separation and detection of heparan sulfate disaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Analytical method for determination of disaccharides derived from keratan sulfates in human serum and plasma by high-performance liquid chromatography/turbo-ionspray ionization tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Prenatal mucopolysaccharidosis II (Hunter): a pathogenetic study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Biochemical and histopathological studies on patients with mucopolysaccharidoses, two of whom had been treated by fibroblast transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

Analytical method of heparan sulfates using high-performance liquid chromatography turbo-ionspray ionization tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2009.10.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMGME.2009.10.001

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/19932038

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48401176&oldid=2196879500"